An outcome of the trial at the Boston Childrens Hospital.
Ann: FDA Grants Rare Pediatric Disease Designation for Revascor, page-4
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.06 |
Change
-0.020(1.85%) |
Mkt cap ! $1.238B | |||
| Open | High | Low | Value | Volume |
| $1.07 | $1.09 | $1.05 | $1.954M | 1.829M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 35776 | $1.06 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.07 | 137827 | 20 |
View Market Depth
| Last trade - 13.11pm 12/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.06 |
Change
-0.020 ( 1.91 %) |
||||
| Open | High | Low | Volume | ||
| $1.07 | $1.09 | $1.06 | 417442 | ||
| Last updated 13.28pm 12/06/2024 ? | |||||
| MSB (ASX) Chart |